Order byBest matchMost fresh

Peter Marks resigns from FDA, slams RFK

Digest more
Top News
Impacts
Reactions and opinions
STAT |
Marks said that he had attempted to answer the concerns of Health and Human Services Secretary Robert F. Kennedy Jr., regarding the safety of common childhood vaccinations.
Politico |
Vaccine makers’ stocks fell as the market opened Monday, with most companies’ stocks staying down at close.
Wall Street Journal |
Marks, who played a crucial role in Operation Warp Speed and championed accelerated drug approvals, announced he was stepping down, citing irreconcilable differences with Health and Human Services Sec...

Read more on News Digest

As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency is heading for the exit. | In resigning as director of the FDA’s Center for Biologics Evaluation and Research,
Peter Marks, FDA’s top vaccine regulator, forced out
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
Industry alarm as FDA's CBER head Peter Marks resigns
Dr Marks formally resigned from his post on 28th March and is due to step down on 5th April, and his resignation letter addressed to acting FDA Commissioner Sara Brenner leaves no doubt as to the reason – the undermining of confidence in vaccines under the leadership of Kennedy and President Donald Trump.
The Peter Marks effect
The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine regulator Dr. Peter Marks, openly worrying that his exit portends an antiscience shift at the agency.
Biotech Stocks Tumble on Reports FDA's Top Vaccine Regulator to Leave
Greg Nash/Pool via REUTERS (Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned,
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio
How Peter Marks' FDA departure is impacting pharma, biotech stocks
The abrupt resignation announcement that came late on Friday, March 28, from Peter Marks, who heads the U.S. FDA's Center for Biologics Evaluation and Research, has sent reverberations throughout the pharma and biotech industries.
Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out
Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK,
US FDA insider Steele replaces Marks as top vaccine official, for now
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine scientist Peter Marks.
New FDA commissioner signed off on vaccine chief’s ouster: Reports
Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his first acts as chief, according to multiple reports. Marks, who led the FDA’s vaccine division for more than eight years,
BioSpace19h
FDA Layoffs Continue as Former Commissioner Robert Califf Speaks Out
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were reportedly underway Tuesday, with CDER Office of New Drugs Director Peter Stein added to the list of casualties.
Feedback